Rigid gas permeable contact lens deposition measured via radiolabeled proteinsFebruary 15th 2023
The Biosciences group of the Centre for Ocular Research and Education (CORE) determined protein deposits on rigid gas permeable contact lens via radioactive counts by using a radiolabeled lysozyme in an artificial tear solution.
Digging into the 6-month first-in-human clinical trial data from SpyGlass PharmaFebruary 14th 2023
Patrick Mooney, CEO of SpyGlass Pharma, sits down to discuss the 6-month first-in-human clinical trial data of their drug delivery platform with bimatoprost, which is implanted during routine cataract surgery.
6-month data from first-in-human trials shows promise for bimatoprost-eluting IOLFebruary 3rd 2023
SpyGlass Pharma presented new data at the Glaucoma 360 New Horizons Forum that supports the use of their proprietary drug delivery platform to lower IOP in patients with glaucoma or ocular hypertension.